Jianwei Zhang

EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy

Wenfeng Fang, Jianwei Zhang, Shaodong Hong et al. · Oncotarget · 2014 · 390 citations · Full text

Life Sciences, Cancer Biology, Oncology +16

Remodeling of the immune and stromal cell compartment by PD-1 blockade in mismatch repair-deficient colorectal cancer

Jianxia Li, Cheng Wu, Huabin Hu et al. · Cancer Cell · 2023 · 339 citations · Full text

Medicine, Immunology, Oncology +16

Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trial

Huabin Hu, Liang Kang, Jianwei Zhang et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 296 citations

Medicine, Oncology, Immunotherapy +15

<p>m<sup>6</sup>A methyltransferase METTL3 suppresses colorectal cancer proliferation and migration through p38/ERK pathways</p>

Ru Deng, Yi‐Kan Cheng, Shubiao Ye et al. · OncoTargets and Therapy · 2019 · 162 citations · Full text

Medicine, Molecular Biology, Oncology +17

Association of renal injury with nitric oxide deficiency in aged SHR: Prevention by hypertension control with AT1 blockade

Xin Zhou, Nosratola D. Vaziri, Jianwei Zhang et al. · Kidney International · 2002 · 63 citations · Full text

Medicine, Geriatric Medicine, Nephrology +16